STOCK TITAN

Protara Therapeutics: Janus Henderson reports 0% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Janus Henderson Group Ltd. reported zero beneficial ownership of Protara Therapeutics, Inc. common stock as of September 30, 2026, representing 0.0% of the class. It reported zero sole or shared voting and dispositive power. The Managed Portfolios have the right to receive dividends and sale proceeds from securities held in their respective accounts; none owns more than 5% of Protara common stock.

Beneficial ownership 0 shares Protara Therapeutics common stock as of September 30, 2026
Percent of class 0.0% Protara Therapeutics common stock
beneficial owner regulatory
"may be deemed to be the beneficial owner of 0 common stock"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
voting discretion regulatory
"exercise investment and/or voting discretion on behalf of the Managed Portfolios"
dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 0"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Managed Portfolios regulatory
"collectively referred to herein as Managed Portfolios"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Protara Therapeutics (JHG) shares did Janus Henderson report beneficially owning?

Janus Henderson Group Ltd. reported zero shares of Protara common stock, or 0.0% of the class, as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





74365U107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



JANUS HENDERSON GROUP Ltd.
Signature:Kristin Mariani
Name/Title:Head of North America Compliance
Date:11/16/2026
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

Keep reading